Business Description
The Cooper Companies Inc
NAICS : 339115
SIC : 3851
6101 Bollinger Canyon Road, Suite 500, San Ramon, CA, USA, 94583
Description
Cooper Companies operates two units: CooperVision and CooperSurgical. Accounting for approximately 75% of total sales, CooperVision is the the second-largest player in the oligopolistic contact lens market. Over 50% of CooperVision's sales are in international territories. The second unit, CooperSurgical, develops and manufactures diagnostic and surgical products for gynecologists and obstetricians, including the Paragard IUD, which Cooper acquired from Teva in 2017.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.11 | |||||
| Equity-to-Asset | 0.6 | |||||
| Debt-to-Equity | 0.5 | |||||
| Debt-to-EBITDA | 4.08 | |||||
| Interest Coverage | 17.59 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 3.26 | |||||
| Beneish M-Score | -2.4 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 4.8 | |||||
| 3-Year EBITDA Growth Rate | 6 | |||||
| 3-Year EPS without NRI Growth Rate | 176.1 | |||||
| 3-Year FCF Growth Rate | 3.2 | |||||
| 3-Year Book Growth Rate | 27.9 | |||||
| Future 3-5Y EPS without NRI Growth Rate Industry Rank | -5.56 | |||||
| Future 3-5Y Total Revenue Growth Rate Industry Rank | 7.55 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 64.3 | |||||
| 9-Day RSI | 63.39 | |||||
| 14-Day RSI | 60.14 | |||||
| 6-1 Month Momentum % | -26.24 | |||||
| 12-1 Month Momentum % | -32.83 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.05 | |||||
| Quick Ratio | 0.69 | |||||
| Cash Ratio | 0.24 | |||||
| Days Inventory | 200.97 | |||||
| Days Sales Outstanding | 60.42 | |||||
| Days Payable | 53.81 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.02 | |||||
| Forward Dividend Yield % | 0.02 | |||||
| 5-Year Yield-on-Cost % | 0.02 | |||||
| 3-Year Average Share Buyback Ratio | -0.1 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 65.9 | |||||
| Operating Margin % | 15.69 | |||||
| Net Margin % | 30.2 | |||||
| ROE % | 14.01 | |||||
| ROA % | 9.17 | |||||
| ROIC % | 9.24 | |||||
| ROC (Joel Greenblatt) % | 22.96 | |||||
| ROCE % | 5.81 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 17.51 | |||||
| Forward PE Ratio | 22.73 | |||||
| PE Ratio without NRI | 17.51 | |||||
| Shiller PE Ratio | 26.32 | |||||
| Price-to-Owner-Earnings | 35.49 | |||||
| PEG Ratio | 2.61 | |||||
| PS Ratio | 5.29 | |||||
| PB Ratio | 2.35 | |||||
| Price-to-Tangible-Book | 11.85 | |||||
| Price-to-Free-Cash-Flow | 34.13 | |||||
| Price-to-Operating-Cash-Flow | 23.89 | |||||
| EV-to-EBIT | 36.99 | |||||
| EV-to-Forward-EBIT | 29.91 | |||||
| EV-to-EBITDA | 22.71 | |||||
| EV-to-Forward-EBITDA | 19.88 | |||||
| EV-to-Revenue | 6.22 | |||||
| EV-to-Forward-Revenue | 5.5 | |||||
| EV-to-FCF | 40.24 | |||||
| Price-to-Projected-FCF | 1.6 | |||||
| Price-to-DCF (Earnings Based) | 0.7 | |||||
| Price-to-DCF (FCF Based) | 2.2 | |||||
| Price-to-Median-PS-Value | 1.05 | |||||
| Price-to-Peter-Lynch-Fair-Value | 3.08 | |||||
| Price-to-Graham-Number | 3.04 | |||||
| Earnings Yield (Greenblatt) % | 2.71 | |||||
| Forward Rate of Return (Yacktman) % | 8.19 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Gurus Latest Trades with NYSE:COO
Executives
EMBED
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 3,139.5 | ||
| EPS (TTM) ($) | 19.04 | ||
| Beta | 0.9 | ||
| Volatility % | 26.85 | ||
| 14-Day RSI | 60.14 | ||
| 14-Day ATR ($) | 7.317313 | ||
| 20-Day SMA ($) | 321.1145 | ||
| 12-1 Month Momentum % | -32.83 | ||
| 52-Week Range ($) | 284.01 - 463.59 | ||
| Shares Outstanding (Mil) | 49.34 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
The Cooper Companies Inc Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||